Clobazam
- Product NDC
- 0527-1681
- 11-digit product format
- 005271681
- Labeler code
- 0527
- Product ID
- 0527-1681_8163e0c2-de80-4c4f-a06c-fac2b47e1d48
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clobazam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- ANDA212092
- Marketing category
- ANDA
- Marketing start
- 2019-10-30
- Marketing end
- 0000-00-00
- Substance
- CLOBAZAM
- Active strength
- 10 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0527-1681-01 | 00527168101 | 100 TABLET in 1 BOTTLE (0527-1681-01) | 100 tablet | 2019-10-30 | 0000-00-00 | No | No | Current |